close
close

Bronstein, Gewirtz & Grossman LLC Announces Class Action Lawsuit for Seastar Medical Holding Corp. Investors Who Suffered Substantial Losses!

Bronstein, Gewirtz & Grossman LLC Announces Class Action Lawsuit for Seastar Medical Holding Corp. Investors Who Suffered Substantial Losses!

NEW YORK, July 8, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. (“Seastar” or “the Company”) (NASDAQ: ICU; ICUCW) and certain of its officers.

Class Definition

This lawsuit seeks damages against the defendants for alleged violations of federal securities laws on behalf of all persons and entities who purchased or otherwise acquired Seastar securities between October 31, 2022And March 26, 2024inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s website: www.bgandg.com/ICU.

Case details

The complaint alleged that Defendants made materially false and misleading statements, and/or failed to disclose materially adverse information, regarding the Company’s business, operations and compliance policies, including allegations that: (1) SeaStar and/or Legacy SeaStar had deficient compliance controls and procedures related to the Humanitarian Device Exemption (“HDE”) application; (2) as a result, there were deficiencies in the HDE application, the FDA was unlikely to approve the HDE application in its current form, and the regulatory outlook for the selective cytopheretic device was overstated; (3) SeaStar understated the true scope and severity of deficiencies in its financial controls and procedures, while overstating Defendants’ efforts to address them; (4) as a result, SeaStar failed to properly account for the classification of certain outstanding warrants and the prepaid forward agreement; and (5) as a result, SeaStar was likely to restate one or more of its previously issued financial statements; and (6) as a result, SeaStar’s business and financial prospects after the merger were overstated.

And after?

A class action has already been filed. If you would like to view a copy of the complaint, you can visit the firm’s website: www.bgandg.com/ICU or you can contact Master Peretz Bronstein or its Customer Relations Manager, Nathan Millerof Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you have suffered a loss at Seastar, you have up to September 3, 2024to ask the court to appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as lead plaintiff.

It costs you nothing

We represent investors in class actions on a contingency fee basis. This means that we will ask the court to reimburse us for costs and attorneys’ fees, typically a percentage of the total amount recovered, only if we are successful in our case.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm representing investors in securities fraud class actions and shareholder derivative actions. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Lawyer Advertising. Past results do not guarantee similar results.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein Or Nathan Miller
332-239-2660 | (protected email)

SOURCE Bronstein, Gewirtz & Grossman, LLC